Thyroxine Sodium Tablets IP 75 mcg | DTHYO-75

Thyroxine Sodium Tablets IP 75 mcg (DTHYO-75) is a pharmaceutical product offered by DR.D Pharma. Designed to cater to the needs of individuals with thyroid disorders, this medication provides a standardized dosage of 75 micrograms of thyroxine sodium.

Thyroxine sodium, also known as levothyroxine, is a synthetic form of the thyroid hormone thyroxine (T4). It plays a crucial role in regulating the body’s metabolism, energy production, and growth. In cases where the thyroid gland fails to produce adequate amounts of thyroxine, a condition known as hypothyroidism, supplementation with thyroxine sodium becomes essential.

DTHYO-75 tablets are formulated with precision to ensure consistent and reliable dosing. Each tablet contains 75 micrograms of thyroxine sodium as the active ingredient, along with other necessary excipients. These tablets are intended for oral administration and are conveniently packed for easy consumption.

The primary goal of DTHYO-75 is to restore and maintain the normal levels of thyroid hormone in the body, thereby alleviating the symptoms associated with hypothyroidism. By providing an appropriate dosage of thyroxine, this medication aids in regulating metabolism, enhancing energy levels, promoting healthy growth, and maintaining overall well-being.

It is important to note that DTHYO-75 should only be used under the supervision of a healthcare professional. The dosage and duration of treatment will be determined based on individual patient requirements, as determined by the prescribing physician. Regular monitoring of thyroid hormone levels and periodic medical check-ups are typically advised to ensure optimal treatment outcomes.

As with any medication, DTHYO-75 may have potential side effects or interactions with other medications or medical conditions. It is crucial to consult a healthcare professional or refer to the product’s prescribing information for comprehensive details on precautions, warnings, and potential adverse effects.

DR.D Pharma is committed to providing high-quality pharmaceutical products, and DTHYO-75 exemplifies their dedication to delivering effective treatments for individuals with hypothyroidism. With its accurate dosage and adherence to pharmaceutical standards, DTHYO-75 aims to contribute to the management of thyroid disorders and improve the quality of life for patients in need.